Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells

Author
Siegl, Frantisek
Publication date
2024Published in
Biomarker ResearchPublisher / Publication place
BioMed CentralVolume / Issue
12 (1)ISBN / ISSN
ISSN: 2050-7771ISBN / ISSN
eISSN: 2050-7771Funding Information
MSM//SVV260519
MSM//EF16_019/0000785
MSM//CZ.02.1.01/0.0/0.0/16_019/0000785
MZ0//NV19-03-00501
MSM//LX22NPO5102
MSM/LM/LM2015064
Metadata
Show full item recordCollections
This publication has a published version with DOI 10.1186/s40364-024-00563-3
Abstract
Small noncoding RNAs play an important role in various disease states, including cancer. PIWI proteins, a subfamily of Argonaute proteins, and PIWI-interacting RNAs (piRNAs) were originally described as germline-specific molecules that inhibit the deleterious activity of transposable elements. However, several studies have suggested a role for the piRNA-PIWI axis in somatic cells, including somatic stem cells. Dysregulated expression of piRNAs and PIWI proteins in human tumors implies that, analogously to their roles in undifferentiated cells under physiological conditions, these molecules may be important for cancer stem cells and thus contribute to cancer progression. We provide an overview of piRNA biogenesis and critically review the evidence for the role of piRNA-PIWI axis in cancer stem cells. In addition, we examine the potential of piRNAs and PIWI proteins to become biomarkers in cancer.
Keywords
Cancer, Cancer stem cells, PIWI proteins, PIWI-interacting RNAs, piRNAs
Permanent link
https://hdl.handle.net/20.500.14178/2240License
Full text of this result is licensed under: Creative Commons Uveďte původ 4.0 International
